$24.95 $0.47 (1.9%)

04:30 PM EDT on 07/09/20

Meridian Bioscience, Inc. (NASDAQ:VIVO)

CAPS Rating: 2 out of 5

A fully-integrated life science company whose principal businesses are development, manufacture, sale and distribution of diagnostic test kits; manufacture and distribution of bulk antigens and reagents; and manufacture of proteins and other biologicals.

Current Price $24.95 Mkt Cap $1.1B
Open $24.55 P/E Ratio 49.90
Prev. Close $24.95 Div. (Yield) $0.00 (0.0%)
Daily Range $24.24 - $25.25 Volume 640,415
52-Wk Range $5.51 - $25.25 Avg. Daily Vol. 878,420

Caps

How do you think NASDAQ:VIVO will perform against the market?

Add Stock to CAPS Watchlist

All Players

443 Outperform
13 Underperform
 

All-Star Players

44 Outperform
5 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:VIVO Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

DODEA (24.67)
Submitted December 29, 2008

Meridian Biosciences has been a great pick for me since 1989. It was one of the very first stocks I owned, and my second DRIP. It has very strong financials, an intelligent business plan, and many products in its pipeline. This is an excellent… More

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

Recent Community Commentary

Read the most recent pitches from players about VIVO.

Recs

0
Member Avatar DaytradingStars (86.07) Submitted: 6/20/2020 11:48:59 PM : Outperform Start Price: $18.50 NASDAQ:VIVO Score: +32.94

Q4.5 WS4.5 MOMOA- EPS-A

Recs

0
Member Avatar TMFBuilt2Last (21.08) Submitted: 2/20/2020 5:55:27 PM : Outperform Start Price: $8.13 NASDAQ:VIVO Score: +213.54

Meridian previously announced it was providing reagents to help with coronavirus testing. The stock bounced on it. Its business besides that has been stabilizing from past investments. Two catalysts going forward are the additional business from the outbreak (short term) and the resumption of the dividend when the business allows (long term).

Recs

0
Member Avatar yooperking (55.02) Submitted: 6/2/2015 9:52:16 AM : Outperform Start Price: $15.98 NASDAQ:VIVO Score: +7.13

Dividend yield of 4.4% is tops in the biotech industry.Meridian has paid a dividend for 20 years and has never cut it; and they have zero debt on their Balance Sheet.

Leaderboard

Find the members with the highest scoring picks in VIVO.

Score Leader

RandolphFL

RandolphFL (21.75) Score: +192.45

The Score Leader is the player with the highest score across all their picks in VIVO.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
TMFBuilt2Last 21.08 2/21/2020 Outperform 5Y $8.13 +207.13% -6.41% +213.54 1 Comment
RandolphFL 21.75 3/23/2009 Underperform NS $12.28 +103.40% +295.85% +192.45 0 Comment
marcet 72.81 3/25/2009 Underperform 5Y $12.11 +106.19% +290.44% +184.25 0 Comment
tilolo76 67.67 10/30/2019 Outperform 3Y $9.84 +153.76% +3.79% +149.97 0 Comment
pinkdiamond < 20 9/16/2008 Underperform NS $18.08 +38.09% +176.49% +138.40 0 Comment
furiouszz68 < 20 4/9/2008 Underperform 5Y $24.36 +2.51% +138.54% +136.03 0 Comment
TMFNosediveflip 95.15 7/18/2008 Underperform NS $16.23 +53.87% +156.83% +102.96 0 Comment
XMFKnightly 83.41 7/18/2008 Underperform NS $16.23 +53.87% +156.83% +102.96 0 Comment
slateslate 58.73 4/18/2008 Underperform 1Y $18.71 +33.46% +135.27% +101.81 0 Comment
zpalqm < 20 1/25/2017 Outperform 5Y $10.59 +135.69% +37.49% +98.20 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for VIVO.